The innovative propositions will be exhibited at Glasgow Science Centre on Wednesday 20 November 2019.
A publication aligned to the Precision Medicine project will be launched at the event.
GSA graduate, Erlend Prenderghast’s, Trial Seek, one of the propositions for Precision Medicine in cancer care to be shown at the Can Do summit
In 2018 final year students in the Innovation School at The Glasgow School of Art researched and created designs for Precision Medicine in cancer care as part of project working with 20 medical and healthcare professionals. The project was delivered in partnership with the Institute of Cancer Sciences at the University of Glasgow led by Professor Nicol Keith.
Looking into the future where Precision Medicine has evolved the students considered what might happen in a cancer landscape ten years from now. Reflecting on the underlying complexities surrounding the future of health, technological acceleration and human agency, they have envisioned a future context, and produced products, services and experiences for the people who might live and work within it. These proposals were presented in Degree Show 2019.
Now these propositions are set to be showcased at the Can Do Summit, a major showcase of innovation and technology, next week. The summit not only aims to help SMEs to maximise the potential of innovation in developing their businesses, but will also demonstrate how innovation and creativity are core to tackling the future challenges facing society.
“The Precision Medicine project was a major example of how our Innovation School students are bringing creative thinking to future challenges facing society by working collaboratively with leading academic and industry experts from other disciplines” says Iain Aitchison, Programme Director, Innovation School at the GSA.
“The opportunity to showcase this work in the context of the Can Do Summit underlines the contribution that the GSA is making to Scotland’s creative landscape both as a knowledge incubator and generator of innovative propositions in an emerging field.”
Among the proposals devised by GSA graduates as final year students were Erlend Prenderghast’s TrialSeekand Benjamin Alexander Laing’s Capsule.Erlendlooked at the challenges in recruiting people for cancer trials. His approach,TrialSeek, is a service which gathers and analyses data on an individual’s lifestyle and environment so as to match them with clinical trials. By using this data is would be possible to match the right person with the right trial at the right time. In Capsule Benjamin addressed the dual challenges of how denial is used as a coping mechanism and cancer patients wishing not to be defined by their condition. Benjamin’s approach disrupts the current medication model though a service that helps patients track their own personal progression and offers them the chance to live their lives as they intend to.
A publication aligned to the Precision Medicine project will be launched at the event.
For full details of the Can Do Summit visit: https://www.candoinnovation.scot
Ends
For further information contact on GSA Innovation School:
Lesley Booth,
07799414474